These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 7810628)
1. Role of interleukin-6 and prostaglandins in the effect of monocyte-conditioned medium on osteoclast formation. Kanatani M; Sugimoto T; Fukase M; Chihara K Am J Physiol; 1994 Dec; 267(6 Pt 1):E868-76. PubMed ID: 7810628 [TBL] [Abstract][Full Text] [Related]
2. Dexamethasone stimulates osteoclast-like cell formation by directly acting on hemopoietic blast cells and enhances osteoclast-like cell formation stimulated by parathyroid hormone and prostaglandin E2. Kaji H; Sugimoto T; Kanatani M; Nishiyama K; Chihara K J Bone Miner Res; 1997 May; 12(5):734-41. PubMed ID: 9144339 [TBL] [Abstract][Full Text] [Related]
3. Enhancement by conditioned medium of stretched calvarial bone cells of the osteoclast-like cell formation induced by parathyroid hormone in mouse bone marrow cultures. Soma S; Matsumoto S; Takano-Yamamoto T Arch Oral Biol; 1997 Mar; 42(3):205-11. PubMed ID: 9188990 [TBL] [Abstract][Full Text] [Related]
4. The effects of parathyroid hormone or 1,25-dihydroxyvitamin D3 on monocyte-osteoclast fusion. Teti A; Volleth G; Carano A; Zambonin Zallone A Calcif Tissue Int; 1988 May; 42(5):302-8. PubMed ID: 3135098 [TBL] [Abstract][Full Text] [Related]
5. Interaction of triiodothyronine with 1alpha,25-dihydroxyvitamin D3 on interleukin-6-dependent osteoclast-like cell formation in mouse bone marrow cell cultures. Schiller C; Gruber R; Ho GM; Redlich K; Gober HJ; Katzgraber F; Willheim M; Hoffmann O; Pietschmann P; Peterlik M Bone; 1998 Apr; 22(4):341-6. PubMed ID: 9556133 [TBL] [Abstract][Full Text] [Related]
6. Involvement of dual signal transduction systems in the stimulation of osteoclast-like cell formation by parathyroid hormone and parathyroid hormone-related peptide. Kaji H; Sugimoto T; Kanatani M; Fukase M; Chihara K Biochem Biophys Res Commun; 1993 Jul; 194(1):157-62. PubMed ID: 8392835 [TBL] [Abstract][Full Text] [Related]
7. The biological roles of the third component of complement in osteoclast formation. Sato T; Abe E; Jin CH; Hong MH; Katagiri T; Kinoshita T; Amizuka N; Ozawa H; Suda T Endocrinology; 1993 Jul; 133(1):397-404. PubMed ID: 8319587 [TBL] [Abstract][Full Text] [Related]
8. 17Beta-estradiol antagonizes effects of 1alpha,25-dihydroxyvitamin D3 on interleukin-6 production and osteoclast-like cell formation in mouse bone marrow primary cultures. Schiller C; Gruber R; Redlich K; Ho GM; Katzgraber F; Willheim M; Pietschmann P; Peterlik M Endocrinology; 1997 Nov; 138(11):4567-71. PubMed ID: 9348179 [TBL] [Abstract][Full Text] [Related]
9. SC-19220, a prostaglandin E2 antagonist, inhibits osteoclast formation by 1,25-dihydroxyvitamin D3 in cell cultures. Inoue H; Tsujisawa T; Fukuizumi T; Kawagishi S; Uchiyama C J Endocrinol; 1999 May; 161(2):231-6. PubMed ID: 10320820 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase. Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698 [TBL] [Abstract][Full Text] [Related]
11. Effect of 24R,25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells. Yamato H; Okazaki R; Ishii T; Ogata E; Sato T; Kumegawa M; Akaogi K; Taniguchi N; Matsumoto T Calcif Tissue Int; 1993 Mar; 52(3):255-60. PubMed ID: 8481842 [TBL] [Abstract][Full Text] [Related]
12. Effect of 24,25-dihydroxyvitamin D3 in osteoclasts. Matsumoto T; Yamato H; Okazaki R; Kumegawa M; Ogata E Proc Soc Exp Biol Med; 1992 Jun; 200(2):161-4. PubMed ID: 1579577 [TBL] [Abstract][Full Text] [Related]
13. Effect of 1,25-dihydroxyvitamin D3 on the proliferation of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes. Kanatani M; Sugimoto T; Fukase M; Chihara K Biochem Biophys Res Commun; 1993 Jan; 190(2):529-35. PubMed ID: 8427595 [TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro. Okazaki R; Toriumi M; Fukumoto S; Miyamoto M; Fujita T; Tanaka K; Takeuchi Y Endocrinology; 1999 Nov; 140(11):5060-5. PubMed ID: 10537132 [TBL] [Abstract][Full Text] [Related]
15. Estrogen blocks parathyroid hormone (PTH)-stimulated osteoclast-like cell formation by selectively affecting PTH-responsive cyclic adenosine monophosphate pathway. Kaji H; Sugimoto T; Kanatani M; Nasu M; Chihara K Endocrinology; 1996 Jun; 137(6):2217-24. PubMed ID: 8641168 [TBL] [Abstract][Full Text] [Related]
16. Carboxyl-terminal parathyroid hormone fragments stimulate osteoclast-like cell formation and osteoclastic activity. Kaji H; Sugimoto T; Kanatani M; Miyauchi A; Kimura T; Sakakibara S; Fukase M; Chihara K Endocrinology; 1994 Apr; 134(4):1897-904. PubMed ID: 8137758 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 does not mediate the stimulation by prostaglandin E2, parathyroid hormone, or 1,25 dihydroxyvitamin D3 of osteoclast differentiation and bone resorption in neonatal mouse parietal bones. Holt I; Davie MW; Braidman IP; Marshall MJ Calcif Tissue Int; 1994 Aug; 55(2):114-9. PubMed ID: 7953976 [TBL] [Abstract][Full Text] [Related]
18. Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene. Matsuzaki K; Katayama K; Takahashi Y; Nakamura I; Udagawa N; Tsurukai T; Nishinakamura R; Toyama Y; Yabe Y; Hori M; Takahashi N; Suda T Endocrinology; 1999 Feb; 140(2):925-32. PubMed ID: 9927325 [TBL] [Abstract][Full Text] [Related]
19. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. Kanatani M; Sugimoto T; Kaji H; Kobayashi T; Nishiyama K; Fukase M; Kumegawa M; Chihara K J Bone Miner Res; 1995 Nov; 10(11):1681-90. PubMed ID: 8592944 [TBL] [Abstract][Full Text] [Related]
20. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Takahashi N; Yamana H; Yoshiki S; Roodman GD; Mundy GR; Jones SJ; Boyde A; Suda T Endocrinology; 1988 Apr; 122(4):1373-82. PubMed ID: 3345718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]